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Methods
Human CPC isolation
Myocardial samples (~200mg each) were obtained from the right atrial appendage of subjects with cardiovascular disease, aged 22-86 years (total subjects included in study, n=119). All subjects had given informed consented to take part in the study (NREC #08/ H1306/91).
Samples were stored in saline on ice until ready to process (~1hr). All steps were performed at 4°C unless stated otherwise. Briefly, cardiac tissue was minced then digested with collagenase II (0.3mg/ml; Worthington Laboratories) in Dulbecco's Modified Eagle's Medium (DMEM; Sigma-Aldrich) at 37°C in a series of sequential digestions for 3 minutes each. Enzymatically released cells were filtered through a 40µm cell strainer (Becton Dickinson, BD) and collected in enzyme quenching media (DMEM + 10% FBS). The isolated cardiac cells were collected by centrifugation at 400g for 10 min, resuspended in incubation media (PBS, 0.5% BSA, 2 mM EDTA), and passed through an OptiPrep 
Flow cytometry and FACS
The c-kit pos , CD45 neg , CD31 neg human CPCs were analysed for hematopoietic, mesenchymal, and endothelial cell markers using a FACSCanto II™ flow cytometer (BD) as previously described (Lewis, Henning et al. 2014 
Cell culture
Human CPCs were cultured on CELLstart™ (ThermoFisher Scientific)-coated cultureware in growth medium, which is composed of (1:1) Dulbecco's MEM/Ham's F12 (DMEM/F12; Sigma-Aldrich) and Neurobasal A medium (ThermoFisher Scientific) containing 10%
Stemulate® pooled human platelet lysate (Cook medical, USA), 2mM L-alanyl-L-glutamine (ThermoFisher Scientific), B27 and N2 supplements (ThermoFisher Scientific), leukemia inhibitory factor (LIF) (10ng/ml; Millipore), bFGF (10ng/ml; Peprotech), EGF (20ng/ml; Peprotech), insulin-transferrin-selenite (ITS; ThermoFisher Scientific), 1%
penicillin/streptomycin (ThermoFisher Scientific), 0.1% gentamicin (ThermoFisher Scientific), and 0.1% Fungizone™ (ThermoFisher Scientific) in a humidified hypoxic incubator at 37°C, 5% CO 2 , 2% O 2 .
Immunocytochemistry
Human CPCs were either freshly isolated or grown in culture and then directly cytospun onto poly-lysine-coated slides using a Shandon Cytospin 4 Cytocentrifuge (ThermoFisher Scientific). Slides were immediately fixed using Shandon Cell-Fixx (ThermoFisher Scientific 
Q-FISH analysis
Freshly isolated human CPCs were cytospun and fixed as described above. To perform Q-FISH, slides were prepared using a telomere PNA FISH kit (Dako) according to the manufacturer's instructions. In brief, slides were incubated in 95% ethanol for 5 min and washed in Tris-buffered saline (TBS; 2 min), fixed in formaldehyde (3.7%) in PBS (2 min), washed in TBS (2 x 5 min), and a pre-treatment solution applied at 1:2000 in TBS (10 min).
Slides were washed again with TBS (2 x 5 min), dehydrated in cold ethanol series (70%, 80%, 95%, 2 min each), and air dried. The PNA hybridization mixture (10μl) containing Cy-3-conjugated (C 3 TA 2 ) 3 peptide nucleic acid (PNA) probe was added to the cells, a coverslip (18 × 18 mm) was then applied, followed by DNA denaturation (5 min at 80°C 
Proliferation, clonogenicity, cardiosphere formation and cardiomyocyte differentiation assays in vitro
A BrdU incorporation assay (Roche) was used to determine cell proliferation, as previously described (Ellison, Torella et al. 2011) .. In brief, 2.5 x 10 3 CPCs were plated in 24 well plates and serum-starved for 6 h in DMEM/F12 medium. Medium was then replaced with growth medium and BrdU was added, 1μg/ml every 8 hours. Cells were fixed after 24 hours and BrdU incorporation was assessed using a BrdU detection kit (Roche) according to the manufacturer's instructions (Supplementary Table 2 ). Nuclei were counterstained with DAPI (Sigma-Aldrich). Cells were viewed and imaged using an ApoTome fluorescent microscope (Zeiss). A minimum of 10 random fields of view at x20 magnification were analysed and number of BrdU-positive cells expressed as a percent of total nuclei.
Human CPCs (P2-P3) were serially diluted and deposited into CTS CELLstart pre-coated 96-well plates (Corning Inc., USA) at 1 cell per well, as described previously (Vicinanza, Aquila et al. 2017) . Individual cells were cultured in growth medium which was refreshed every 3 days. Wells containing CPC colonies were scored by bright-field microscopy after 7 days of culture to determine clonal efficiency. The clonogenicity of the human CPCs was expressed as the percent number of clones generated from the total number of single cells plated. A minimum of 3 plates were quantified per subject.
Cardiomyocyte differentiation was induced as previously described (Smith, Lewis et al. 2014 , Vicinanza, Aquila et al. 2017 . Briefly, 5x10 4 human CPCs were treated with oxytocin (100 nM; Sigma-Aldrich) for 72 h. Human CPCs were then transferred to a 10cm bacteriological dish containing LIF-deprived CPC growth medium to generate spheres. Spheres were transferred to laminin (1μg/ml; Sigma-Aldrich)-coated coverslips within 24 well plates and incubated with cardiomyogenic differentiation medium: alpha-MEM, 2% FCS, ascorbic acid (50μg/ml), dexamethasone (1 μM), beta-glycerol phosphate (10 mM), 1% penicillinstreptomycin, 0.1% gentamicin, and 0.1% Fungizone. Differentiating cultures were maintained for up to 14 d, replacing the medium containing specific growth factors on days 1 and 5. From days 1-4, cells were incubated with medium containing BMP-2 (10 ng/ml; Peprotech), BMP-4 (10 ng/ml; Peprotech), and TGF-β1 (5 ng/ml; Peprotech). From days 5 to 14, cells were incubated with medium containing 150 ng/ml Dkk-1 (150ng/ml; R&D).
Medium was replaced every 3 days and cultures were fixed and analysed at 14 days.
Cardiosphere formation was quantified from a minimum of 10 images per subject taken at x4 magnification from random fields. The number of cardiospheres were expressed per cm 2 .
Cardiosphere size was determined from the same images by measuring the diameter of the spheres using ImageJ software (Fiji, USA). A minimum of 20 spheres per donor were measured. Cardiomyocyte differentiation was measured by immunostaining of differentiated cultures using Nkx2.5 (1:20, overnight 4°C) and α-sarcomeric actin (1:50, 1 hour 37°C)
antibodies (Supplementary Table 2 ). Secondary antibodies were Alexa Fluor 488, or 594 (Life Technologies). Nuclei were counterstained with DAPI. A minimum of 5 images at x20 magnification from random fields were taken per subject for quantification of Nkx2.5 pos cells per total nuclei and fluorescent intensity of α-sarcomeric actin expression.
Senescence induction, conditioned media, and multiplex SASP protein analysis
To induce senescence pharmacologically, cycling-competent CPCs were exposed to Rosiglitazone (0.1 µM; Calbiochem) or Doxorubicin (0.2 µM; Calbiochem) at ~70%
confluence for 24 h. Medium was removed and cell cultures washed three times with PBS before replacing with fresh growth medium. Culture medium was refreshed every 3 days and CPCs were maintained for up to 35 days. Cells were analysed for SA-β-gal (as described above) and p16 INK4A expression over this time course by quantifying the total number of positive cells per total nuclei from a minimum of 5 random fields at 10x and 20x magnification respectively. Conditioned media (CM) were prepared by pre-washing cyclingcompetent or senescent CPC cultures (5x10 5 cells) three times with PBS, then exposing them to RMPI 1640 containing 1 mM sodium pyruvate, 2 mM glutamine, MEM (minimum essential medium), vitamins, MEM non-essential amino acids, and antibiotics (ThermoFisher Scientific) for 24 h. CM was filtered through a 0.2 µM filter and stored at -20°C until ready for use or analysis. Luminex® xMAP technology was used to quantify SASP factors in CM.
Multiplexing analysis was performed using the Luminex 100 system (Luminex) by Eve Technologies using human multiplex kits (Millipore).
PKH26 cell labelling
Human cycling-CPCs, doxorubicin (Dox)-induced Senescent-CPCs or c-kit neg cells (5x10  5 ) were harvested and washed in serum-free DMEM/F12 medium before being resuspended in Prior to echocardiography, mice were weighed and anaesthetised in an anaesthetic chamber at 0.5ml/min O 2 and 4% Isoflurane. The depth of anaesthesia was assessed by a change in the breathing pattern of the mouse and the absence of the pinch withdrawal reflex. Once under deep anaesthesia, mice were placed onto an imaging station (Vevo, Netherlands). Anaesthesia was regulated to maintain heart rate between 400-500 beats per minute monitored by ECG recordings, and body temperature was maintained at 37 ± 0.5  C using a temperature probe.
Mice were depilated and ultrasound gel was applied onto the vicinity of the chest (Aquasonic 100, Germany). Parasternal long and short axis images of the heart were taken using the to 2% isoflurane at 0.5ml/min for the duration of the surgical procedure. Proceeding depilation, the thoracic area was sterilised and a midline incision along the skin overlying the sternum was performed to expose the muscle. A left-sided thoracotomy between the fourth and fifth rib was performed to expose the heart. Following the separation of the pericardial sac, the coronary artery was ligated using 6-0 silk suture (Ethicon, US) using the left atrium and aorta as entry and exit landmarks, respectively. The force of the suture was determined by the appearance of a color change in the left ventricle. Following the permanent ligation, the heart was assessed for atrial fibrillation for a 10 minute interval and was preceded by the closure of the thorax and the skin using 5-0 silk suture (Ethicon, US Echocardiography measurements were taken at baseline (BL), 7 days, and 28 days post-MI, after which mice were sacrificed.
Senolytic drug treatment, viability, TUNEL staining in vitro
Cycling-competent human CPCs and Senescent-CPCs, induced by Doxorubicin (as described 
Co-culture assays
CPCs were plated in the bottom well of 0.4µm pore Costar Transwell 24-well plates (Corning) and, once attached, were induced to senescence with Doxorubicin as described above and maintained for 30 days. Cycling-competent CPCs were plated at low density (200 cells/well) onto the Transwell membrane 1 day prior to co-culture. Cycling-competent CPCs were then combined with either senescent CPCs or cultured alone (control wells) and maintained for 7 days. At this time point, cultures were either fixed for analysis, conditioned media were collected, or senolytics were applied to transwells for 3 days to selectively clear senescent cells (as described above). After senolytic clearance, a sub-set of wells were fixed and stained for SA-β-gal (as described previously) to confirm effective clearance. Cyclingcompetent CPCs were maintained for a further 7 days, at which point conditioned media were collected for luminex analysis (as described above) and cultures fixed for analysis.
INK-ATTAC mice and drug treatments
The following experimental procedures were conducted in accordance with Mayo Clinic
Institutional Animal Care and Use Committee (IACUC) guidelines. Both stocks of INK-ATTAC and C57BL/6 wild type mice were bred and aged at Mayo Clinic. The generation and characterization of INK-ATTAC mice has been described previously (Baker, Wijshake et al. 2011 , Xu, Palmer et al. 2015 . Mice were housed in ventilated cages and maintained in a pathogen-free, accredited facility under a 12 h light-dark cycle with constant temperature (23°C) and access to food (standard mouse diet, Lab Diet 5053, St. Louis, MO) and water ad libitum. 24-32 month old mice were randomly assigned to treatment groups and injected intraperitoneally (i.p.) with either vehicle (60% Phosal-50PG, 30%
PEG-400, and 10% ethanol) or AP20187 (B/B homodimerizer, Clontech, 10 mg AP20187/kg body mass) or administered by oral gavage vehicle (66% Phosal-50PG, 10%
ethanol, and 30% PEG-400) or senolytic drugs (5mg/kg Dasatinib + 50mg/kg Quercetin diluted in vehicle) for 3 consecutive days every 2 weeks for 2 months as shown in Fig 6a. This dosing regime was chosen because it has been shown to be effective at clearing senescent cells in chronologically aged INK-ATTAC mice in previous studies (Xu, Palmer et al. 2015 , Roos, Zhang et al. 2016 . Another group of INK-ATTAC mice aged 3 months (n=10) and 22 months (n=10) were randomly assigned to treatment groups and injected intraperitoneally (i.p.) with either vehicle or AP20187 for 2 consecutive days every 2 weeks for 2 months as shown in Supplementary Fig 10c . These mice were injected (i.p) with EdU (123 mgkg -1 ) 2 hours prior to sacrifice.
Tissue collection, immunohistochemistry, and confocal imaging
Mice were sacrificed at either 4 days or 28 days after MI with the hearts arrested in diastole with cadmium chloride solution (Sigma), removed, and embedded in OCT compound (Tissue-Tek) at _ 80°C before preparing 10μm sections. To identify transplanted cells, transverse sections were identified by PKH26 fluorescent labelling (Sigma-Aldrich) and nuclei counterstained with DAPI. Sections were assessed for co-localisation of PKH26 labelling and myocytes or vascular structures using antibodies against α-sarcomeric actin (cardiomyocytes; 1:250 dilution, 1hr at 37°C) or vWF (endothelial cells; 1:250 dilution, 1 hr at 37°C) respectively. Images were taken using a confocal microscope (Nikon A1) at x63 magnification. To quantify PKH26-cell engraftment, the total number of PKH26 pos cells per total nuclei were quantified from a minimum of 5 random fields at x20 magnification. To measure scar size, sections from the apex and mid-region of the heart were stained with Haematoxylin Van Gieson (HVG, Fisher Scientific, UK) using standard procedures. Fibrosis was visualised using a light microscope (Zeiss, Axioscope MTB2004) connected to Axiovision software (Zeiss) where sections were captured at x5 magnification and stitched to reconstruct an image of a section of the whole heart. Analysis was performed using Image J software (NIH). Data were acquired by measuring the area of fibrosis (red) across the apex and mid-regions of the heart using an average of 5 images per heart and the area of left ventricle and were expressed as a percentage Mean ± SEM. (Zeiss Apotome fluorescent microscope, Oberkochen, Germany). Proliferating cells were identified using antibodies against BrdU (Roche) (Supplementary Table 1 ) and nuclei counterstained with DAPI. A minimum of 5 random fields of view at x20 magnification were analysed and data expressed as percent of BrdU-positive cells per total nuclei. Sections were also assessed for number of newly formed myocytes using antibodies against BrdU (Roche) and α-sarcomeric actin INK-ATTAC and wild-type C57BL/6 mice were sacrificed 4 days after the last dose of the last course of treatment with AP20187 or senolytic drugs. Hearts were explanted and cut into two parts. One half was fixed in 4% formaldehyde for 24 hrs and embedded in paraffin. The other half was snap-frozen in liquid nitrogen for subsequent RT-qPCR analyses as described below. 10μm transverse heart sections were cut on a microtome (Leica) and mounted onto microscope slides. Antigen retrieval was achieved using Target Retrieval Solution, Citrate pH 6 (DAKO). Sections were stained for c-kit (1:500 dilution, overnight at 4°C), Sca-1 (1:500 dilution, overnight at 4°C), CD45 (1:1000 dilution, 1 hr at 37°C), CD34 (1:1000 dilution, 1 hr at 37°C), CD31 (1:1000 dilution, 1 hr at 37°C), Ki67 (1:500 dilution, 1 hr at 37°C) and α- 
Real-time quantitative polymerase chain reaction (RT-qPCR)
To measure human gene expression, total cellular RNA was extracted and reverse transcription was performed as described previously . RT-qPCR reactions were run with SYBR Green PCR Master Mix (Bio-Rad) and primers (IDT) (Supplementary Table 3 ). Human GAPDH, B-actin, and TBP were used as reference genes. qPCR conditions were as follows: 95°C for 5 min, 40 × (95°C for 15s, 60°C for 30s, and 72°C for 30s). All reactions were run in triplicate on a CFX-connect Real-Time PCR System (Bio-Rad) and analyzed using Graphpad software.
From mouse hearts, total RNA was extracted using Trizol (Thermo Fisher Scientific) and reverse transcription was performed using an M-MLV reverse transcriptase kit as described previously (Xu et al. 2015, PNAS) 
Statistical analysis
Data are reported as mean ± SEM or mean ± SD. The data displayed normal variance. The experiments were not randomized, except for the in vivo animal studies as described above.
The investigators were blinded to allocation during experiments and outcome assessment.
Significance between 2 groups was determined by Student's t-test and in multiple comparisons by the analysis of variance (ANOVA) using GraphPad Prism (GraphPad Software). In the event that ANOVA justified post-hoc comparisons between group means, these were conducted using Tukey's multiple-comparisons test. Viability of human CPCs exposed to different senolytic drugs for 3 days. The red line denotes cell viability on day 0 prior to senolytic exposure. (c) Dox-induced Sen-CPCs were exposed to different senolytics for 3 days and clearance was quantified using SA-β-gal staining relative to untreated control. (d) D+Q exposure resulted in an increased number of apoptotic cells in Sen-CPC cultures after 16h. All data are Means±SEM, n=2 independent experiments *P<0.0001 by two-way ANOVA.
